Lipotoxicity as a Barrier for T Cell-Based Therapies
Nowadays, T-cell-based approaches play an increasing role in cancer treatment. In particular, the use of (genetically engineered) T-cells has heralded a novel era for various diseases with previously poor outcomes. Concurrently, the relationship between the functional behavior of immune cells and th...
Main Authors: | Romy Böttcher-Loschinski, Judit Rial Saborido, Martin Böttcher, Sascha Kahlfuss, Dimitrios Mougiakakos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/9/1182 |
Similar Items
-
Role of CAR T Cell Metabolism for Therapeutic Efficacy
by: Judit Rial Saborido, et al.
Published: (2022-11-01) -
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
by: Nouria Jantz-Naeem, et al.
Published: (2023-02-01) -
Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions
by: Afolarin A. Otunla, et al.
Published: (2024-02-01) -
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
by: Aaron R Lim, et al.
Published: (2020-05-01) -
Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
by: Priyanka Maridhi Nanjireddy, et al.
Published: (2023-03-01)